IP Library Granted Patent US 7,435,572
Granted Patent B2
US 7,435,572 · App. 10/407,637 · Granted Oct 14, 2008

Methods and compositions for DNA manipulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,435,572
App. No.
10/407,637
Granted
Oct 14, 2008
Kind
B2
Abstract

Methods and compositions are provided for generating a single-stranded extension on a polynucleotide molecule, the single-stranded extension having a desired length and sequence composition. Methods for forming single-stranded extensions include: the use of a cassette containing at least one nicking site and at least one restriction site at a predetermined distance from each other and in a predetermined orientation; or primer-dependent amplification which introduces into a polynucleotide molecule, a modified nucleotide which is excised to create a nick using a nicking agent. The methods and compositions provided can be used to manipulate a DNA sequence including introducing site specific mutations into a polynucleotide molecule and for cloning any polynucleotide molecule or set of joined polynucleotide molecules in a recipient molecule such as a vector of choice.

Claims (23)

1. A nicking agent, comprising: an artificial mixture of two or more enzymes in the absence of a polynucleotide containing a modified nucleotide, wherein at least one of the enzymes is a DNA glycosylase and at least one of the enzymes is a cleaving enzyme; and wherein in the presence of the polynucleotide containing the modified nucleotide, the mixture cleaves at the modified nucleotide;

the DNA glycosylase and the cleaving enzyme having an activity ratio of at least 2:1, the activity ratio being the ratio of a first rate of forming an abasic site by excision of the modified nucleotide from the polynucleotide by DNA glycosylase to a second rate of cleaving at the abasic site in the polynucleotide by the cleaving enzyme, the first and second rates determined for a single predetermined molar amount of the modified nucleotide in the polynucleotide.

2. A nicking agent according to claim 1 , wherein the cleaving enzyme generates a 5′ phosphate in the polynucleotide molecule after excision of the modified nucleotide.

3. A nicking agent according to claim 1 , wherein the cleaving enzyme is selected from a FPG glycosylase/AP lyase and a EndoVIII glycosylase/AP lyase.

4. A nicking agent according to claim 1 , wherein the at least one cleaving enzyme generates a 3′ OH in the polynucleotide molecule after excision of the modified nucleotide.

5. A nicking agent according to claim 4 , wherein the cleaving enzyme is EndoIV endonuclease.

6. A nicking agent according to claim 1 , wherein the two or more enzymes generate a 5′ phosphate and a 3′ OH in the polynucleotide molecule after excision of the modified nucleotide.

7. A nicking agent according to claim 6 , wherein the two or more enzymes are selected from; (i) EndoIV endonuclease and EndoVIII glycosylase/AP lyase, and (ii) EndoIV endonuclease and FPG glycosylase/AP lyase.

8. A nicking agent according to claim 1 , wherein the modified nucleotide is a deoxyuridine (U).

9. A nicking agent according to claim 1 , wherein the modified nucleotide is an 8-oxo-guanine.

10. A nicking agent according to claim 1 , wherein the modified nucleotide is a deoxyinosine.

11. A nicking agent according to claims 4 or 8 , wherein the two or more enzymes are UDG glycosylase and EndoIV endonuclease.

12. A nicking agent according to claims 2 , 8 or 9 , wherein the two or more enzymes are UDG glycosylase and FPG glycosylase/AP lyase.

13. A nicking agent according to claims 4 or 10 , wherein the two or more enzymes are AlkA glycosylase and EndoIV endonuclease.

14. A nicking agent according to claims 2 or 8 , wherein the two or more enzymes are UDG glycosylase and EndoVIII glycosylase/AP lyase.

15. A nicking agent according to claims 6 or 8 , wherein the two or more enzymes are UDG glycosylase, EndoIV endonuclease and EndoVIII glycosylase/AP lyase.

16. A nicking agent according to claims 6 , 8 or 9 , wherein the two or more enzymes are UDG glycosylase, EndoIV endonuclease and FPG glycosylase/AP lyase.

17. A nicking agent according to claims 2 or 10 , wherein the two or more enzymes are AlkA glycosylase and EndoVIII glycosylase/AP lyase.

18. A nicking agent according to claims 2 or 10 , wherein the two or more enzymes are AlkA glycosylase and FPG glycosylase/AP lyase.

19. A kit, comprising a nicking agent according to claim 1 and a linearized vector.

20. A kit according to claim 19 , further comprising a DNA polymerase with 3′ to 5′ exonuclease activity.

21. A kit according to claim 19 , further comprising a T4 DNA ligase.

22. A kit according to claim 19 , further comprising at least one sequencing primer.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2003
From: BITINAITE, JURATE
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 013952/0074 →